Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Adult Hodgkin lymphoma AND MYC, c-Myc, 4609, ENSG00000136997 AND Prognosis
91 results:

  • 1. [Clinical study of mature B-cell lymphoma in 11 children with chromosome 11 long-arm abnormalities].
    Zhang N; Duan YL; Zhou CJ; Jin L; Yang J; Huang S; Zhang M; Li N
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):924-929. PubMed ID: 38185522
    [No Abstract]    [Full Text] [Related]  

  • 2. Epstein-Barr virus-encoded EBNA2 downregulates ICOSL by inducing miR-24 in B-cell lymphoma.
    Leopizzi M; Mundo L; Messina E; Campolo F; Lazzi S; Angeloni A; Marchese C; Leoncini L; Giordano C; Slack F; Trivedi P; Anastasiadou E
    Blood; 2024 Feb; 143(5):429-443. PubMed ID: 37847858
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. BET inhibitors induce NF-κB and E2F downregulation in hodgkin and Reed-Sternberg cells.
    Fernández S; Díaz E; Rita CG; Estévez M; Montalbán C; García JF
    Exp Cell Res; 2023 Sep; 430(2):113718. PubMed ID: 37468057
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. myc rearrangement and concurrent high protein expression of C-myc/Bcl2 carry an adverse prognosis in diffuse large B-cell lymphoma.
    Wang X; He J; He H; Shuai Y; Wang L; Li Y; Huang Y; Yu K; Zhao M; Xie T; Li D
    Ann Diagn Pathol; 2023 Oct; 66():152165. PubMed ID: 37348414
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Investigating In Situ Expression of c-myc and Candidate Ubiquitin-Specific Proteases in DLBCL and Assessment for Peptidyl Disruptor Molecule against c-myc-USP37 Complex.
    Kamran DES; Hussain M; Mirza T
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985413
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The evaluation of gene mutation profiles by next-generation sequencing in diffuse large B-cell lymphoma.
    Özçalımlı A; Erdoğdu İH; Turgutkaya A; Yavaşoğlu İ; Döger FK; Bolaman AZ
    Int J Lab Hematol; 2023 Jun; 45(3):310-316. PubMed ID: 36576110
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Large B-cell lymphoma with IRF4 gene rearrangements: Differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients.
    Berg HE; Peterson JF; Lee HE; McPhail ED
    Hum Pathol; 2023 Jan; 131():108-115. PubMed ID: 36470475
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Richter transformation in Chronic Lymphocytic Leukemia.
    Innocenti I; Benintende G; Tomasso A; Fresa A; Autore F; Larocca LM; Laurenti L
    Hematol Oncol; 2023 Aug; 41(3):293-300. PubMed ID: 36433773
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Two cases of follicular lymphoma with myc gene abnormalities that presented with bone marrow necrosis.
    Miyazawa Y; Takei H; Kobayashi N; Akashi N; Sairenji Y; Sugisaki M; Naito C; Ishikawa T; Shimizu H; Ishizaki T; Yokohama A; Tsukamoto N; Yoshida Y; Matsumura N; Takayama Y; Handa H
    J Clin Exp Hematop; 2022 Dec; 62(4):208-216. PubMed ID: 36261333
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Decreased CD11c-positive dendritic cells in the tumor microenvironment predict double-hit/triple-hit genotype and survival in diffuse large B-cell lymphoma.
    Yuan CT; Chuang SS; Cheng PY; Chang K; Wang H; Tsai JH; Liau JY; Chou WC
    J Pathol Clin Res; 2022 Sep; 8(5):436-447. PubMed ID: 35715938
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Expression of the RUVBL1 Component of the R2TP Complex Correlates with Poor prognosis in DLBCL.
    Lone M; Shadang M; Akhter Q; Kumar M; Mallick S; Gogia A; Nilima N; Chauhan SS; Mir RA
    Pathobiology; 2022; 89(3):146-156. PubMed ID: 35078195
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial.
    Chiappella A; Diop F; Agostinelli C; Novo M; Nassi L; Evangelista A; Ciccone G; Di Rocco A; Martelli M; Melle F; Moia R; Motta G; Righi S; Santambrogio E; Tucci A; Balzarotti M; Ladetto M; Pileri SA; Gaidano G; Vitolo U;
    Br J Haematol; 2022 Mar; 196(5):1184-1193. PubMed ID: 34951009
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis.
    Ren S; Cai Y; Hu S; Liu J; Zhao Y; Ding M; Chen X; Zhan L; Zhou X; Wang X
    Biochem Pharmacol; 2021 Jun; 188():114576. PubMed ID: 33930347
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma.
    Youssef Y; Karkhanis V; Chan WK; Jeney F; Canella A; Zhang X; Sloan S; Prouty A; Helmig-Mason J; Tsyba L; Hanel W; Zheng X; Zhang P; Chung JH; Lucas DM; Kauffman Z; Larkin K; Strohecker AM; Ozer HG; Lapalombella R; Zhou H; Xu-Monette ZY; Young KH; Han R; Nurmemmedov E; Nuovo G; Maddocks K; Byrd JC; Baiocchi RA; Alinari L
    Haematologica; 2021 Nov; 106(11):2927-2939. PubMed ID: 33054136
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Paediatric Burkitt lymphoma patient-derived xenografts capture disease characteristics over time and are a model for therapy.
    Forde S; Matthews JD; Jahangiri L; Lee LC; Prokoph N; Malcolm TIM; Giger OT; Bell N; Blair H; O'Marcaigh A; Smith O; Kenner L; Bomken S; Burke GAA; Turner SD
    Br J Haematol; 2021 Jan; 192(2):354-365. PubMed ID: 32880915
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Patterns of immune checkpoint protein expression in myc-overexpressing aggressive B-cell non-hodgkin lymphomas.
    Landsburg DJ; Koike A; Nasta SD; Svoboda J; Schuster SJ; Wasik MA; Caponetti GC
    Cancer Immunol Immunother; 2021 Mar; 70(3):869-874. PubMed ID: 32857184
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.
    Hill HA; Qi X; Jain P; Nomie K; Wang Y; Zhou S; Wang ML
    Blood Adv; 2020 Jul; 4(13):2927-2938. PubMed ID: 32598477
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CD56-positive diffuse large B-cell lymphoma/leukemia with
    Liu Y; Shen J; Awal Issah M; Liu T; Zhou H; Fu H
    J Int Med Res; 2020 May; 48(5):300060520918087. PubMed ID: 32363958
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Brentuximab vedotin demonstrates an objective response in a patient with refractory CD30+ primary mediastinal B-cell lymphoma.
    Badri N; Ngamdu KS; Torabi A; Guar S
    J Cancer Res Ther; 2020; 16(1):183-185. PubMed ID: 32362635
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Combination of CD47 and signal-regulatory protein-α constituting the "don't eat me signal" is a prognostic factor in diffuse large B-cell lymphoma.
    Kazama R; Miyoshi H; Takeuchi M; Miyawaki K; Nakashima K; Yoshida N; Kawamoto K; Yanagida E; Yamada K; Umeno T; Suzuki T; Kato K; Takizawa J; Seto M; Akashi K; Ohshima K
    Cancer Sci; 2020 Jul; 111(7):2608-2619. PubMed ID: 32342603
    [TBL] [Abstract] [Full Text] [Related]  


    of 5.